However, in active inflammatory bowel disease (IBD), the conversion process of pro-inflammatory monocyte-like cells cells (CD11chighCCR2+CX3CR1+) into tolerant tissues (CD11c–CCR2–CX3CR1–) is impeded. Here, ITGAX is linked to inflammatory bowel disease.